Synthesis of natural (-)-hamigeran B

Tetrahedron Letters

Volumn 44, Issue 42, 2003, Pages 7731-7733

  Clive, Derrick L J ^a   Wang, Jian ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Hamigeran B; Hydrogenolysis; Meyers' lactam; Silyl groups

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; HAMIGERAN B; IODINE; LACTAM; LITHIUM DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CHEMICAL BOND; CHEMICAL REACTION; DRUG SYNTHESIS; HYDROGENATION; HYDROGENOLYSIS;

EID: 0141794065     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2003.08.089     Document Type: Article

References (26)

1. Wellington K.D., Cambie R.C., Rutledge P.S., Bergquist P.R. J. Nat. Prod. 63:2000;79-85.
2. Details of the biological tests have not been published; the antiviral activity is described as follows: Hamigeran B.showed 100% virus inhibition against both the Herpes and Polio viruses, with only slight cytotoxicity throughout the whole well at a concentration of 132 μg per disk.
3. Nicolaou K.C., Gray D., Tae J. Angew. Chem., Int. Ed. 40:2001;3675-3678.
4. Nicolaou K.C., Gray D., Tae J. Angew. Chem., Int. Ed. 40:2001;3679-3683.
5. 3) (personal communication from Professor K. C. Nicolaou).
6. Clive D.L.J., Wang J. Angew. Chem., Int. Ed. 42:2003;3406-3409.
7. Snyder L., Meyers A.I. J. Org. Chem. 58:1993;7507-7515.
8. Sandham D.A., Meyers A.I. J. Chem. Soc., Chem. Commun. 1995;2511-2512.
9. Gannett P.M., Nagel D.L., Reilly P.J., Lawson T., Sharpe J., Toth B. J. Org. Chem. 53:1988;1064-1071.
10. Cf. Barluenga J., Fernández J.R., Rubiera C., Yus M. J. Chem. Soc., Perkin Trans. 1. 1988;3113-3118.
11. Cf. McGhie J.F., Ross W.A., Evans D., Tomlin J.E. J. Chem. Soc. 1962;350-355.
12. Cf. Betancourt de Perez R.M., Fuentes L.M., Larson G.L., Barnes C.L., Heeg M.J. J. Org. Chem. 51:1986;2039-2043.
13. McKennon M.J., Meyers A.I., Drauz K., Schwarm M. J. Org. Chem. 58:1993;3568-3571.
14. Cf. Burgess L.E., Meyers A.I. J. Org. Chem. 57:1992;1656-1662.
15. Made from 2,5-dimethylphenol by the method of Ref. 14, except that the formyl group was best generated by benzylic bromination (Ref. 15), followed by oxidation with DMSO (Ref. 16).
16. Gore M.P., Gould S.J., Weller D.D. J. Org. Chem. 57:1992;2774-2783.
17. Leed A.R., Boettger S.D., Ganem B. J. Org. Chem. 45:1980;1098-1106.
18. Helms A., Heiler D., McLendon G. J. Am. Chem. Soc. 114:1992;6227-6238.
19. Epstein W.W., Sweat F.W. Chem. Rev. 67:1967;247-260.
20. Mizutani T., Wada K., Kitagawa S. J. Org. Chem. 65:2000;6097-6106.
21. 2 groups of the ethyl substituent.
22. Chiralcel OD column (0.46×5 cm); eluant 4:1 i-PrOH-hexane; flow rate 1.0 mL/min; detection at 230 nm, temperature 25°C; sample concentration ca. 1 mL/mg in MeOH, injection volume 20 μL.
23. Bernard A.M., Ghiani M.R., Piras P.P., Rivoldini A. Synthesis. 1987;287-288.
24. Fujisaki S., Eguchi H., Omura A., Okamoto A., Nishida A. Bull. Chem. Soc. Jpn. 66:1993;1576-1579.
25. Krohn K., Bernhard S., Flörke U., Hayat N. J. Org. Chem. 65:2000;3218-3222.
26. 2 284.17764, found 284.17735.